HIV and Drug Abuse Interventions among Pregnant Women in Drug Abuse Treatment

The summary for the HIV and Drug Abuse Interventions among Pregnant Women in Drug Abuse Treatment grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
HIV and Drug Abuse Interventions among Pregnant Women in Drug Abuse Treatment: This RFA invites applications for studies testing interventions to prevent or reduce HIV risk among pregnant women in drug abuse treatment through: 1) targeted behavioral HIV prevention and risk reduction interventions; and 2) behavioral interventions aimed at improving adherence to prenatal care regimens among HIV-positive, pregnant drug-abusers. A total of $1.5 million is anticipated for funding approximately 4-6 meritorious research projects. The grant mechanisms eligible for funding through this RFA are the small grant (R03), the exploratory/developmental grant (R21), and the standard research grant (R01) mechanisms. Eligible institutions include for-profit, non-profit, domestic, foreign, public, private, and certain units of state and local government also faith and community based, eligible Federal. Eligible principal investigators are any applicants with the skills, knowledge, and resources to carry out the proposed research. An applicant may no! t submit more than one application in response to this RFA for which he or she is the Principal Investigator or Co-Investigator. An applicant who is the Principal Investigator on one application may serve as a consultant on other applications submitted in response to this RFA. Application materials are available through the NIH website (http://grants.nih.gov/grants/forms.htm), and technical assistance in preparing applications is available from the contact people listed in this announcement. Telecommunications for the hearing impaired is available at: TTY 301-451-0088.
Federal Grant Title: HIV and Drug Abuse Interventions among Pregnant Women in Drug Abuse Treatment
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-05-008
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Mar 21, 2005
Posted Date: Jan 24, 2005
Creation Date: Jan 24, 2005
Archive Date: Apr 20, 2005
Total Program Funding: $1,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 4
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments City or township governments
Additional Information on Eligibility
Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants
PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional)
Rapid Assessment of Drug Abuse: Smart City Tools (R43/R44 - Clinical Trial Optional)
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Tr...
Rapid Assessment of Drug Abuse: Smart City Tools (R41/R42 - Clinical Trial Optional)
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-I...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Drug Screening with Biofabricated 3-D Skin Disease Tissue Models (U18 Clinical Trial Not A...
Postdoctoral Research Associate Training (PRAT) Program (Fi2)
Methods to Improve Reproducibility of Human iPSC Derivation, Growth and Differentiation (S...
Sponsored Programs Administration Development (SPAD) Program (UC2 - Clinical Trial Not All...
PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com